MENU
EIKN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Eikon Therapeutics (EIKN) Ownership - Who owns Eikon Therapeutics?

Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
678.9M
P/E Ratio
N/A
Total Cash
512.18M
Projected Growth
N/A
Total Debt
254.83M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
9.46
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
EIKN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details